OR4A47 Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Concanavalin A | 11028-71-0 | sc-203007 sc-203007A sc-203007B | 50 mg 250 mg 1 g | $117.00 $357.00 $928.00 | 17 | |
Concanavalin A binds to and cross-links specific glycoproteins, which could cluster OR4A47 and its associated signaling components, leading to receptor internalization and signaling attenuation. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $442.00 | 3 | |
Pertussis toxin irreversibly ADP-ribosylates Gαi proteins, preventing their interaction with OR4A47, thereby inhibiting OR4A47-mediated inhibitory pathways. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels and promoting protein kinase A (PKA) activation, which can phosphorylate OR4A47, leading to reduced receptor sensitivity and signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC), which can lead to phosphorylation of OR4A47, resulting in receptor desensitization and inhibition of its signaling cascade. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein inhibits tyrosine kinases that are necessary for the phosphorylation of proteins involved in OR4A47-mediated signaling pathways, reducing the receptor's activation. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
BAPTA-AM is a calcium chelator that can sequester intracellular Ca2+, a second messenger in OR4A47 signaling, leading to the inhibition of the receptor-mediated response. | ||||||
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $97.00 $144.00 $648.00 | 47 | |
KT5720 is a PKA inhibitor that prevents the phosphorylation of downstream targets in the OR4A47 signaling cascade, thereby inhibiting the receptor's function. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $149.00 $210.00 $714.00 $2550.00 $10750.00 $21410.00 $40290.00 | 5 | |
Suramin antagonizes P2 purinergic receptors, which could inhibit downstream signaling events that interact with the OR4A47 pathway, leading to a reduction in OR4A47-mediated signaling. | ||||||
Mibefradil dihydrochloride | 116666-63-8 | sc-204083 sc-204083A | 10 mg 50 mg | $209.00 $848.00 | 4 | |
Mibefradil blocks T-type calcium channels, which are involved in the regulation of intracellular calcium levels, a key component in OR4A47 signaling, thus inhibiting OR4A47 activity. | ||||||